News | May 20, 2025
Zydus Wellness records a growth of 30% in net profit in FY25
EBITDA for the period rose by 23.2% to Rs. 3,797 million
EBITDA for the period rose by 23.2% to Rs. 3,797 million
CuraTeQ Biologics receives approval for biosimilar Zefylti from UK’s MHRA
Glatiramer Acetate is the generic version of Copaxone 20 mg/ml, 40 mg/ml, Single-Dose Prefilled Syringes
Over the last 24 years, the company's sales has grown from Rs. 478 crores to Rs. 19,022 crores
Niacin is indicated to reduce elevated total cholesterol, LDL cholesterol, apolipoprotein B and triglycerides (TG)
The inspection concluded with 6 observations and none of them were related to Data Integrity
The closing of the Block Acquisition is now expected to be completed by Q3 2025
Zydus MedTech gets rights to market the innovative Transcatheter Aortic Valve Implantation (TAVI) technology in India, Europe and other select markets
Apalutamide is an androgen receptor inhibitor indicated for the treatment of patients with metastatic castration-sensitive prostate cancer
Alkem Medtech to acquire 100% stake of Bombay Ortho
Subscribe To Our Newsletter & Stay Updated
